Switzerland · Series B startup

Who invested in Anergis

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareBiotech

Funding summaryUpdated 26 Oct 2026

$35Mraised across 2 rounds since 2011, from 2 sources

$20MSeries A$15MSeries B
Latest round
Series B, $15MDec 2014
Biggest round
$20MSeries A · Mar 2011
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201220132014
$20MSeries A$15MSeries B
First round
Series A, $20M
Mar 2011
Biggest round
$20M
Series A · Mar 2011
Between rounds
3.7 years
from the last two

The rounds

  1. Dec 2014
    Series B$15M

    No investor was named in the report.

    From a historical funding record

  2. Mar 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

BioMedPartnersPrivate equity1round
VINCI CAPITALPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Anergis

Who invested in Anergis?

Anergis's investors include Sunstone Life Science Ventures, BioMedPartners and VINCI CAPITAL.

How much has Anergis raised?

Anergis has raised $35M across 2 rounds since 2011.

When did Anergis last raise?

Anergis's most recent round was a Series B of $15M in Dec 2014.

What was Anergis's biggest round?

Anergis's largest round on record is $20M (Series A), in Mar 2011.

Who backed Anergis first?

Anergis's first round on record, in Mar 2011, was backed by Sunstone Life Science Ventures, BioMedPartners and VINCI CAPITAL.

What stage is Anergis at?

Anergis's latest named round is a Series B, in Dec 2014.

Where is Anergis based?

Anergis is based in Switzerland.

Companies like Anergis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.